Adocia announces that its partner Tonghua Dongbao has published positive results from three clinical studies conducted on BioChaperone Combo THDB0207 (BC Combo), containing Tonghua Dongbao's insulin glargine and insulin lispro.

These three clinical trials were conducted in Germany on subjects with type 1 diabetes, type 2 diabetes and healthy volunteers of Chinese origin, in comparison with a reference Premix (Humalog Mix25).

These trials demonstrated a good safety and tolerance profile, a more rapid effect which could translate into a reduction in post-prandial hyperglycemia, an improvement in basal control and a reduction in overexposure which could limit hypoglycemia.

Copyright (c) 2023 CercleFinance.com. All rights reserved.